American public education director sells shares worth $3.98 million

325 Capital LLC, a major shareholder in American Public Education Inc. (APEI), sold 133,054 shares for approximately $3.98 million at prices between $29.3637 and $29.829. This sale follows APEI's mixed Q1 2025 results, where EPS missed estimates at $0.41 while revenue beat expectations at $164.6 million; however, Texas Capital Securities initiated coverage with a Buy rating and a $35 price target, citing the positive impact of the Rasmussen University acquisition on APEI's EBITDA and strategic progress, projecting revenue between $650 million and $660 million for FY25.

Analysis

A significant insider sale by 325 Capital LLC, involving the disposition of 133,054 shares of American Public Education Inc. (APEI) for approximately $3.98 million between May 27 and May 29, has been reported; however, 325 Capital retains a substantial holding of 1,055,012 shares. This activity occurs as APEI's stock has demonstrated remarkable strength, delivering a 60% return over the past year and trading near its 52-week high of $30.19. The company, with a $523 million market capitalization, maintains a "GREAT" financial health score according to InvestingPro, which also suggests the stock is slightly undervalued based on its Fair Value analysis. APEI's first-quarter 2025 financial results were mixed: earnings per share of $0.41 missed the forecast of $0.44, but revenue of $164.6 million surpassed the anticipated $161.97 million. More notably, the company showed significant bottom-line improvement, with net income rising to $7.5 million from a $1 million loss in the same quarter of the previous year, and adjusted EBITDA increasing by 25% year-over-year.

The positive financial trajectory is significantly influenced by the strategic acquisition and ongoing integration of Rasmussen University, which has bolstered APEI’s presence in the nursing education sector and contributed to a positive EBITDA swing from a loss in the previous year. This progress underpins the recent initiation of coverage by Texas Capital Securities with a "Buy" rating and a $35.00 price target. The firm highlighted APEI's strategic advancements and expressed optimism that APEI could surpass its fiscal year 2025 earnings guidance, forecasting EBITDA growth of more than 20% year-over-year for FY25. APEI's management has projected FY25 revenue between $650 million and $660 million, with adjusted EBITDA expected to range from $77 million to $87 million, driven by anticipated continued enrollment growth and revenue synergies from institutional consolidation, including Rasmussen's expected contribution to positive operating margins from the fourth quarter onward throughout FY25.

Key Decisions for Investors

• Investors should evaluate the recent insider selling by 325 Capital LLC in the context of their significant remaining stake and APEI's strong underlying fundamentals, including robust stock performance and positive financial health.
• Consider the new 'Buy' rating and $35 price target from Texas Capital Securities, which anticipates APEI may outperform its own optimistic FY25 guidance, largely due to the positive impact and synergies from the Rasmussen University acquisition.
• Monitor upcoming quarterly earnings for sustained revenue growth, evidence of margin expansion from Rasmussen integration, and achievement of enrollment targets to validate the current growth narrative, especially following the Q1 EPS miss.
• Assess APEI's valuation, noting that while the stock trades near its 52-week high, InvestingPro's Fair Value analysis suggests it may be slightly undervalued, potentially offering further upside if strategic initiatives and financial projections materialize.